PMID: 8608490Mar 1, 1996Paper

Antitumor electrochemotherapy: new advances in the clinical protocol

Cancer
C DomengeL M Mir

Abstract

Electrochemotherapy (ECT) is a new antitumor approach that combines systemic bleomycin (BLM) with electric pulses (EP) delivered locally at the tumor site. These EP permeabilize the cells in the tissue, allow BLM delivery inside the cells, and increase BLM cytotoxicity. As an extension of our initial Phase I trial on patients with head and neck squamous cell carcinoma (HNSCC) permeation nodules, we tested variations of ECT protocol to determine how to improve it. Seven patients with multiple and/or large permeation nodules of HNSCC or of salivary or breast adenocarcinoma were treated in 10 sessions. They received BLM followed by runs of four or eight short (100 microseconds) and intense (1000 or 1300 V/cm-1) EP delivered at adjacent positions on the nodules to cover all of the tumor surface. We determined the therapeutic window for EP delivery to be between 8 and 28 minutes after BLM intravenous injection. We showed patient tolerance to a high number of EP, along with ECT feasibility after BLM intraarterial injection or on adenocarcinoma nodules. Clear antitumor effects were obtained, especially in the small nodules. In the largest nodules we observed extended tumor necrosis. Relatively efficient ECT can be performed for large ...Continue Reading

References

Jan 11, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L M MirC Paoletti
Jan 11, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J BelehradekL M Mir
Dec 21, 1991·Biochemical Pharmacology·B PoddevinL M Mir
Mar 1, 1994·The Tohoku Journal of Experimental Medicine·O YamaguchiY Shiraiwa
Jan 1, 1995·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·L M MirP Kourilsky
Jul 30, 1993·Biochemical and Biophysical Research Communications·L G SalfordL M Mir
Jun 8, 1993·Biochimica Et Biophysica Acta·S Orlowski, L M Mir

❮ Previous
Next ❯

Citations

Sep 4, 2014·The British Journal of Oral & Maxillofacial Surgery·Luca Giovanni CampanaCarlo R Rossi
Feb 18, 2011·Future Oncology·Ursula A Matulonis
Mar 10, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J JaroszeskiR Heller
Mar 10, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J JaroszeskiR Heller
May 25, 2011·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Erika KisAndrea Rita Horvath
Mar 14, 2014·Biomedical Engineering Online·Damijan MiklavčičGregor Serša
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·T GotoY Ushio
Apr 17, 2007·Annals of Surgery·John O LarkinGerald C O'Sullivan
Feb 25, 2010·Biomedical Engineering Online·Damijan MiklavcicGregor Sersa
Mar 2, 2013·Radiology and Oncology·Barbara MaliTomaz Jarm
Apr 21, 2001·DNA and Cell Biology·M L LucasR Heller
Mar 6, 1998·Nature Biotechnology·R O Potts, Y A Chizmadzhev
Mar 6, 1998·Nature Biotechnology·M P RolsJ Teissie
Nov 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Harukazu Mashiba, Keiko Matsunaga
Apr 9, 2008·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Mira SadadcharamGerald C O'sullivan
Nov 10, 2009·Expert Review of Anticancer Therapy·Mecker G MöllerGerald C O'Sullivan
May 11, 2010·Expert Review of Vaccines·Sylvia van Drunen Littel-van den Hurk, D Hannaman
May 18, 2010·Expert Review of Anticancer Therapy·Tomaz JarmGregor Sersa
Oct 27, 2007·Expert Opinion on Biological Therapy·Alain LuxembourgDrew Hannaman
Nov 23, 2001·Acta Oto-laryngologica·A FerlitoN Weir
Jan 1, 1997·Critical Reviews in Biotechnology·I Hapala
Jun 27, 2012·Acta Oncologica·Louise Wichmann MatthiessenJulie Gehl
Sep 18, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·B MaliD Miklavcic
Aug 23, 2011·Cancer Treatment Reviews·Gregor SersaMarko Snoj
Jul 7, 2007·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G SersaM Snoj
Nov 5, 2013·The Journal of Membrane Biology·A MahnaZ Shankayi
Oct 4, 2006·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·B M TijinkC R Leemans
Apr 18, 2012·The British Journal of Surgery·L G CampanaC R Rossi
Aug 4, 2011·Bioelectromagnetics·Marie Breton, Lluis M Mir
Nov 9, 2010·Dermatologic Therapy·Alessandro TestoriPier Francesco Ferrucci
Mar 20, 2016·Cancer Chemotherapy and Pharmacology·Ales GroseljMaja Cemazar
Feb 4, 1998·Biophysical Journal·E NeumannJ Frey
Feb 6, 1999·IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society·I DaskalovE Peycheva
Jan 1, 1997·Acta Oto-laryngologica. Supplementum·H A Jääskelä-SaariR Grénman
Jan 12, 2010·Orvosi hetilap·Erika KisJudit Oláh
May 26, 1998·Japanese Journal of Cancer Research : Gann·M CemazarG Sersa
Oct 26, 2000·Japanese Journal of Cancer Research : Gann·M KatoS Orikasa
Nov 4, 2000·International Journal of Cancer. Journal International Du Cancer·A HoriuchiS Fujii
May 18, 2011·Acta Oncologica·Louise Wichmann MatthiessenJulie Gehl

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.